Omi Parikh
Lancashire Teaching Hospitals NHS Foundation Trust(GB)Yale University(US)Royal Preston Hospital(GB)Royal Blackburn Teaching Hospital(GB)East Lancashire Hospitals NHS Trust(GB)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Renal cell carcinoma treatment, Radiopharmaceutical Chemistry and Applications, Bladder and Urothelial Cancer Treatments, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial(2015)1,944 cited
- → Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy(2017)1,740 cited
- → Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial(2018)1,235 cited
- → Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial(2019)636 cited
- → Randomized, Controlled, Double-Blind, Cross-Over Trial Assessing Treatment Preference for Pazopanib Versus Sunitinib in Patients With Metastatic Renal Cell Carcinoma: PISCES Study(2014)438 cited
- →